(Q33975572)

30 July 2017

Clinicopathologic review of 58 patients with biliary papillomatosis (English)

1 reference

30 July 2017

Sang Soo Lee

1

1 reference

30 July 2017

Myung-Hwan Kim

2

1 reference

30 July 2017

Sung Koo Lee

3

1 reference

30 July 2017

Se Jin Jang

4

1 reference

30 July 2017

Moon-Hee Song

5

1 reference

30 July 2017

Kyu-Pyo Kim

6

1 reference

30 July 2017

Hong Ja Kim

7

1 reference

30 July 2017

Dong-Wan Seo

8

1 reference

30 July 2017

Dong Eun Song

9

1 reference

30 July 2017

Eunsil Yu

10

1 reference

30 July 2017

Seung-Gyu Lee

11

1 reference

30 July 2017

Young Il Min

12

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

30 July 2017

1 reference

30 July 2017

100

1 reference

30 July 2017

4

1 reference

30 July 2017

783-793

1 reference

Biliary papillomatosis with the point mutation of K-ras gene arising in congenital choledochal cyst

30 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

Pancreatoscopy and magnetic resonance pancreatography may decrease the margin-positive cases and recurrence rate in surgical therapy of mucinous ductal ectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Biliary papillomatosis: clinical, cholangiographic and cholangioscopic findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Biliary papillomatosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Intraductal papillary neoplasia of the liver associated with hepatolithiasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Expression of MUC1 and MUC2 and carbohydrate antigen Tn change during malignant transformation of biliary papillomatosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Intraductal variant of peripheral cholangiocarcinoma of the liver with Clonorchis sinensis infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Multiple Biliary Papillomatosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

MR cholangiography versus cholangioscopy for evaluation of longitudinal extension of hilar cholangiocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Radiologic features of papillary adenoma and papillomatosis of the biliary tract

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Intrahepatic biliary papillomatosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Clinical studies of mucin-producing cholangiocellular carcinoma: a study of 22 histopathology-proven cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

The value of pancreatoscopy in patients with mucinous ductal ectasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Magnetic resonance cholangiopancreatography is insufficient for the detection of flat lesions in mucinous ductal ectasia: pancreatoscopy may be needed additionally.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

A case of mucin-hypersecreting intrahepatic bile duct tumor associated with pancreatic intraductal papillary mucinous tumor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Preoperative assessment of cholangiocarcinoma: meeting the challenge

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Limitation of cholangiography in assessing longitudinal spread of extrahepatic bile duct carcinoma to the hepatic side

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Percutaneous transhepatic cholangioscopic examination: a necessity for the biliary endoscopist

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Limitations of percutaneous transhepatic cholangioscopy for the diagnosis of the intramural extension of bile duct carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Proximal bile duct cancer. Quality of survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20031

7 January 2021

Identifiers

DOI

10.1002/CNCR.20031

1 reference

30 July 2017

1 reference